x

Virpax Pharmaceuticals, Inc. (Nasdaq:VRPX)

Health Care/Life Sciences • Pharmaceuticals
CIK 1708331
Company

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.

Address
1055 Westlakes Drive
Suite 300
Berwyn, Pennsylvania 19312
Employees
7
Stock Info
Close
$4.3000
Day Range
3.7100 - 4.3400
52 Week Range
2.4020 - 11.7740
Average volume
30.68K
Short Interest
6.24K (02/15/24)
% of Float Shorted
0.72%
Market Cap
$4.41M
Revenue
N/A
Net Income
-$21.65M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$11.6225
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director
Gerald W Bruce
Director, Chief Medical Officer & Executive VP
Jeffrey A Gudin MD
Director
Barbara A Ruskin PhD
Chairman
Eric Floyd PhD, EMBA
Independent Director
Vanila M Singh MD
Independent Director
Jerrold Sendrow
Independent Director
Thani Jambulingam PhD
Independent Director
Michael F Dubin CPA
SEC filings
DateFormEvent
18 Dec, 2024 8-K
13 Dec, 2024 8-K
9 Dec, 2024 DEF 14A
4 Dec, 2024 3
29 Nov, 2024 8-K
26 Nov, 2024 8-K
22 Nov, 2024 8-K
20 Nov, 2024 8-K
20 Nov, 2024 PRE 14A
15 Nov, 2024 8-K
14 Nov, 2024 10-Q
13 Nov, 2024 424B4
12 Nov, 2024 EFFECT
7 Nov, 2024 S-1/A
6 Nov, 2024 CORRESP
6 Nov, 2024 CORRESP
28 Oct, 2024 S-1/A
18 Oct, 2024 S-1/A
10 Oct, 2024 10-K/A
10 Oct, 2024 10-K/A
9 Oct, 2024 8-K/A
7 Oct, 2024 8-K
4 Oct, 2024 8-K
3 Oct, 2024 8-K
3 Oct, 2024 8-K
25 Sep, 2024 8-K
17 Sep, 2024 8-K
16 Sep, 2024 CORRESP
30 Aug, 2024 CORRESP
30 Aug, 2024 CORRESP
26 Aug, 2024 CORRESP
26 Aug, 2024 CORRESP
20 Aug, 2024 CORRESP
20 Aug, 2024 CORRESP
13 Aug, 2024 8-K
13 Aug, 2024 S-1/A
12 Aug, 2024 10-Q
5 Aug, 2024 UPLOAD
30 Jul, 2024 8-K
29 Jul, 2024 S-1
26 Jul, 2024 8-K
24 Jul, 2024 8-K
15 Jul, 2024 8-K
15 Jul, 2024 3
12 Jul, 2024 D
10 Jul, 2024 4
10 Jul, 2024 8-K
10 Jul, 2024 3
9 Jul, 2024 3
9 Jul, 2024 4
9 Jul, 2024 4
9 Jul, 2024 3
8 Jul, 2024 DEFA14A
8 Jul, 2024 8-K
3 Jul, 2024 8-K
12 Jun, 2024 DEF 14A
12 Jun, 2024 ARS
23 May, 2024 SC 13G
17 May, 2024 8-K
16 May, 2024 424B4
14 May, 2024 EFFECT
14 May, 2024 CORRESP
13 May, 2024 10-Q
13 May, 2024 8-K
13 May, 2024 S-1/A
9 May, 2024 CORRESP
3 May, 2024 CORRESP
3 May, 2024 CORRESP
2 May, 2024 8-K
2 May, 2024 S-1/A
2 May, 2024 CORRESP
30 Apr, 2024 8-K
26 Apr, 2024 S-1/A
23 Apr, 2024 UPLOAD
18 Apr, 2024 S-1
5 Apr, 2024 S-8
3 Apr, 2024 8-K
26 Mar, 2024 10-K
26 Mar, 2024 8-K
18 Mar, 2024 8-K
1 Mar, 2024 8-K
31 Jan, 2024 4
31 Jan, 2024 4
31 Jan, 2024 4
31 Jan, 2024 4
31 Jan, 2024 4
31 Jan, 2024 4
31 Jan, 2024 4
31 Jan, 2024 4
31 Jan, 2024 4
2 Jan, 2024 SC 13G/A
29 Dec, 2023 8-K
13 Dec, 2023 8-K
7 Dec, 2023 10-Q
7 Dec, 2023 DEF 14A
7 Dec, 2023 8-K
21 Nov, 2023 PRE 14A
17 Nov, 2023 8-K CEO Change
17 Nov, 2023 8-K
16 Nov, 2023 8-K
15 Nov, 2023 NT 10-Q
11 Oct, 2023 8-K
3 Oct, 2023 3
5 Sep, 2023 8-K
16 Aug, 2023 8-K
16 Aug, 2023 4/A
14 Aug, 2023 8-K
14 Aug, 2023 10-Q
26 Jul, 2023 8-K
22 Jun, 2023 DEFA14A
21 Jun, 2023 4
21 Jun, 2023 8-K
21 Jun, 2023 3
7 Jun, 2023 DEF 14A
7 Jun, 2023 8-K
7 Jun, 2023 ARS
12 May, 2023 8-K
12 May, 2023 10-Q
26 Apr, 2023 4
14 Apr, 2023 8-K
28 Mar, 2023 4
28 Mar, 2023 8-K
28 Mar, 2023 3
22 Mar, 2023 8-K
22 Mar, 2023 10-K
13 Mar, 2023 8-K
17 Feb, 2023 8-K
14 Feb, 2023 SC 13G/A
7 Feb, 2023 4/A
27 Jan, 2023 4
27 Jan, 2023 4
27 Jan, 2023 4
26 Jan, 2023 SC 13G/A
10 Jan, 2023 SC 13G/A
4 Jan, 2023 4
4 Jan, 2023 4
4 Jan, 2023 4
4 Jan, 2023 4
4 Jan, 2023 4
29 Dec, 2022 8-K
22 Nov, 2022 S-8
9 Nov, 2022 8-K
9 Nov, 2022 10-Q
18 Oct, 2022 EFFECT
14 Oct, 2022 CORRESP
13 Oct, 2022 UPLOAD
7 Oct, 2022 S-3
15 Aug, 2022 10-Q
15 Aug, 2022 8-K
25 Jul, 2022 8-K
27 Jun, 2022 8-K
21 Jun, 2022 DEFA14A
15 Jun, 2022 DEF 14A
15 Jun, 2022 DEFA14A
26 May, 2022 4
20 May, 2022 4
20 May, 2022 4
16 May, 2022 8-K
16 May, 2022 10-Q
6 May, 2022 S-8
27 Apr, 2022 4
31 Mar, 2022 10-K
31 Mar, 2022 8-K
15 Mar, 2022 8-K
25 Feb, 2022 4/A
25 Feb, 2022 4/A
25 Feb, 2022 4/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G
4 Feb, 2022 SC 13G
2 Feb, 2022 4
2 Feb, 2022 4
2 Feb, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
4 Jan, 2022 SC 13G/A
24 Nov, 2021 4
22 Nov, 2021 4
15 Nov, 2021 10-Q
15 Nov, 2021 8-K
23 Sep, 2021 SC 13G
21 Sep, 2021 SC 13G
20 Sep, 2021 SC 13G
15 Sep, 2021 424B4
15 Sep, 2021 POS EX
14 Sep, 2021 EFFECT
10 Sep, 2021 FWP
9 Sep, 2021 UPLOAD
9 Sep, 2021 CORRESP
9 Sep, 2021 CORRESP
9 Sep, 2021 S-1
1 Sep, 2021 DRS
10 Aug, 2021 8-K
10 Aug, 2021 10-Q
5 Aug, 2021 4
5 Aug, 2021 3
5 Aug, 2021 3
30 Jul, 2021 8-K
18 May, 2021 8-K
17 May, 2021 10-Q
23 Apr, 2021 S-8
19 Apr, 2021 8-K
13 Apr, 2021 8-K
9 Apr, 2021 4
9 Apr, 2021 4
9 Apr, 2021 4
9 Apr, 2021 4
9 Apr, 2021 4
9 Apr, 2021 4
9 Apr, 2021 4
9 Apr, 2021 4
9 Apr, 2021 4
31 Mar, 2021 10-K
1 Mar, 2021 4
19 Feb, 2021 4
18 Feb, 2021 424B4 IPO completed
18 Feb, 2021 POS EX
16 Feb, 2021 3
16 Feb, 2021 3
16 Feb, 2021 3
16 Feb, 2021 3
16 Feb, 2021 CERT
16 Feb, 2021 S-1MEF
16 Feb, 2021 EFFECT
16 Feb, 2021 3
16 Feb, 2021 3
16 Feb, 2021 3
16 Feb, 2021 3
16 Feb, 2021 3
16 Feb, 2021 SEC STAFF
16 Feb, 2021 3
11 Feb, 2021 CORRESP
11 Feb, 2021 CORRESP
11 Feb, 2021 8-A12B
2 Feb, 2021 S-1/A
8 Jan, 2021 S-1/A
8 Jan, 2021 CORRESP
8 Jan, 2021 FWP
31 Dec, 2020 UPLOAD
16 Dec, 2020 CORRESP
7 Dec, 2020 SEC STAFF
3 Dec, 2020 UPLOAD
20 Nov, 2020 CORRESP
23 Oct, 2020 UPLOAD
9 Oct, 2020 CORRESP
8 Sep, 2020 UPLOAD
Last update:2024-03-06 13:40:55.950712
Virpax Pharmaceuticals, Inc. by TradingView

Sign Up to Subscribe